Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2786 studies found for:    "Hepatitis, Viral, Human"
Show Display Options
Rank Status Study
21 Recruiting Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Conditions: Hepatitis;   Hepatitis C;   Digestive System Diseases;   Flaviviridae Infections;   Hepatitis, Viral, Human;   Liver Diseases;   RNA Virus Infections;   Virus Diseases
Interventions: Drug: MK- 3682B;   Drug: Ribavirin
22 Completed Prospective Study of HIV Infection in Hemophiliacs
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections;   Blood Disease;   Hemophilia A;   Hepatitis, Viral, Human;   Blood Transfusion;   Cytomegalovirus Infections
Intervention:
23 Completed Retrovirus Epidemiology Donor Study-II (REDS-II)
Conditions: Acquired Immunodeficiency Syndrome;   Blood Donors;   Blood Transfusion;   HIV Infections;   HIV-1;   HIV-2;   HTLV-I;   HTLV-II;   Retroviridae Infections;   Hepatitis, Viral, Human;   Hepatitis B;   Hepacivirus;   West Nile Virus
Intervention:
24 Completed Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
Condition: Hepatitis C Virus Infection
Intervention: Drug: LDV/SOF
25 Completed The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates
Conditions: Virus Disease;   DNA Virus Infections;   Hepadnaviridae Infections
Interventions: Biological: Experimental recombinant hepatitis B vaccine, HBIG;   Biological: Active Comparator hepatitis B vaccine;   Biological: Experimental recombinant hepatitis B vaccine;   Biological: Active Comparator recombinant hepatitis B vaccine.;   Biological: Placebo Comparator recombinant hepatitis B vaccine
26 Recruiting Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence Study
Condition: Transplantation
Intervention: Biological: Hepatitis E serology
27 Active, not recruiting Epidemiological Study of Hepatitis E Virus in Maintenance Hemodialysis Patients
Condition: Hepatitis E Virus Infection
Intervention:
28 Withdrawn Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention:
29 Completed
Has Results
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)
Condition: Chronic Hepatitis C Virus
Interventions: Drug: LDV/SOF;   Drug: RBV
30 Completed
Has Results
Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3
Condition: Hepatitis C
Interventions: Drug: SOF;   Drug: PEG;   Drug: RBV
31 Completed
Has Results
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection
Condition: Chronic Hepatitis C Virus
Interventions: Drug: LDV/SOF;   Drug: RBV
32 Completed
Has Results
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV
Condition: Chronic Hepatitis C Virus
Interventions: Drug: LDV/SOF;   Drug: RBV
33 Completed
Has Results
Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
Condition: Hepatitis C Virus
Interventions: Drug: SOF;   Drug: RBV
34 Completed Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention: Drug: peginterferon alfa-2a and ribavirin
35 Completed
Has Results
Safety, Tolerability and Efficacy of 12-weeks of Sovaprevir, ACH-3102 and Ribavirin in Treatment-naive GT-1 HCV Subjects
Condition: Hepatitis C, Chronic
Interventions: Drug: Sovaprevir;   Drug: ACH-3102;   Drug: RBV;   Drug: Placebo
36 Completed Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ypeginterferon alfa-2b;   Drug: Peginterferon alfa-2a
37 Completed Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: GS-9857;   Drug: Placebo to match GS-9857;   Drug: SOF/GS-5816
38 Completed Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus
Condition: Hepatitis C
Interventions: Drug: DCV/ASV/BMS-791325;   Drug: DCV/ASV/BMS-791325 + RBV
39 Approved for marketing Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
Condition: Post-transplant Hepatitis C
Interventions: Drug: Sofosbuvir;   Drug: Ribavirin;   Drug: Pegylated Interferon
40 Terminated Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
Conditions: Hepatitis C;   Depressive Disorder, Major;   Depressive Disorder;   Depression;   HIV Infections
Interventions: Behavioral: Hepatitis C educational support groups;   Behavioral: Cognitive Behavioral Therapy skills based group sessions

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.